57 results about "Joint fluid" patented technology

A joint aspirate-facilitating device is provided including a flexible main panel that is secured to the joint to be aspirated. An inflatable bladder is secured to the main panel and is placed in contact with the soft tissues overlying and surrounding the joint space. The bladder is used to apply pressure to selected areas of the joint to compress the fluid sacs in the joint. An access opening is formed in the main panel designating the location where joint fluid is to be aspirated. The joint fluid is directed to flow to the area of the joint exposed at the access opening based on the shape of the bladder that compresses surrounding areas of the fluid sacs. A conventional hand pump may pressurize the bladder or the bladder may be filled with a viscous gel material to generate pressure. Multiple access openings may be formed on the main panel designating locations where aspiration is to be conducted. For multiple access openings, plugs may be used to fill those openings where aspiration is not conducted, thereby maximizing joint fluid flow only to the selected location where aspiration is to be conducted. An ultrasound probe may be attached and incorporated into the device to confirm joint fluid displacement into the targeted location prior to need aspiration. A disposable molded sterile dressing may applied to the access opening to reduce the risk of infections. The device can be used on any joint of the body, and the particular shape of the main panel and bladder accommodates maximum joint fluid flow to the point where aspiration is desired.

Disposable microfluidic cartridges, potentiostat reader devices, systems, kits, and methods to determine the concentration of analyte reaction products in a patient's specimen, such as: blood, saliva, cerebrospinal fluid, joint fluid or tears. The microfluidic cartridges are disposable, paper-based strips comprising multiple assay layers, each layer comprising: a drop zone for receiving a patient specimen; a filter to remove contaminates, and / or isolate assay reactants; a hydrophilic microfluidic channel to direct movement of the specimen down the cartridge; a centered reaction chamber comprising impregnated enzymes and reagents to chemically react with the filtered specimen to produce an analyte; and a detector mechanism. Multiple analytes can be produced in parallel (e.g. one per layer), or sequentially along one layer. The detector mechanism utilizes electro-analytic methods to facilitate the reader device in quantifying each analyte, and each analyte concentration is wirelessly transmitted to an electronic computing device for storage in a patient's medical record.

This invention relates to: a method for differentiating osteoclast precursor cells (preosteoclasts) into osteoclasts, which comprises culturing the preosteoclasts in the absence of accessory cells; a method for isolating preosteoclasts, which comprises culturing peripheral blood or joint fluid in the absence of cytokine for 1 to 3 weeks; an preosteoclasts, which is obtainable by the above method; a method for differentiating the preosteoclasts obtained by the above method into osteoclasts, which comprises culturing the preosteoclasts in the absence of accessory cell; an osteoclast, which is obtainable by the above method; a method for screening agents for treating metabolic bone diseases, which comprises using the preosteoclasts or the osteoclasts as described above; and agents for treating metabolic bone diseases, which is obtainable by the above screening method.

This invention relates to: a method for differentiating osteoclast precursor cells (preosteoclasts) into osteoclasts, which comprises culturing the preosteoclasts in the absence of accessory cells; a method for isolating preosteoclasts, which comprises culturing peripheral blood or joint fluid in the absence of cytokine for 1 to 3 weeks; an preosteoclasts, which is obtainable by the above method; a method for differentiating the preosteoclasts obtained by the above method into osteoclasts, which comprises culturing the preosteoclasts in the absence of accessory cell; an osteoclast, which is obtainable by the above method; a method for screening agents for treating metabolic bone diseases, which comprises using the preosteoclasts or the osteoclasts as described above; and agents for treating metabolic bone diseases, which is obtainable by the above screening method.

A specific polypeptide related to rheumatoid arthritis and application thereof are provided. The specific polypeptide includes citrulline, wherein at least one side of the citrulline is connected witha citrulline-like amino acid, and a spacer amino acid is also provided between the citrulline and the citrulline-like amino acid. The specific polypeptide provided has high sensitivity and specificity in identifying autoimmune antibodies of patients with rheumatoid arthritis, and can be directly used for the detection of RA autoimmune antibodies, and can also be used to immunize animals to produce polyclonal antibodies or monoclonal antibodies that can be used to detect citrullinated proteins, and to produce identification kits for citrullinated proteins in rheumatoid arthritis serum, joint fluid and body fluids.

The invention relates to the technical field of biology, and particularly relates to a preparation method of a cervus and cucumis polypeptide and application of the cervus and cucumis polypeptide to the preparation of special medical-purpose food. According to the cervus and cucumis polypeptide prepared by the preparation method, an extracting solution is subjected to enzymatic hydrolysis with compound proteinase; tannin and an alkaloid are removed with calcium sulfate; the generation of a sensitizer is avoided; meanwhile, the stability of a product is also improved; the polypeptide prepared by the preparation method is ground into powder; the administration can be carried out through an oral taking way; the convenience of the administration is improved. Shown by an experiment, the cervusand cucumis polypeptide prepared by the preparation method can be used for effectively decreasing contents of IL(Interleukin)-1Beta and TNF (Tumor Necrosis Factor)-Alpha in joint fluid of model rats;an obvious difference is presented compared with a control group, and p is less than 0.05.

The invention discloses a biological agent for preventing and relieving joint sub-health and a preparation method thereof, and belongs to the technical field of biological agents. The biological agent of the present invention contains a plurality of bioactive components and a plurality of active ingredients of Chinese herbs. The bioactive components comprise S-adenosylmethionine, sodium hyaluronate, sodium chondroitin sulfate, vitrin and acetyl glucosamine, can prevent decomposition of proteoglycan by enzyme, provide exogenous hyaluronic acid for human joints, activate synthesis of mucopolysaccharide in the body, and promote synthesis of hyaluronic acid and collagen and cartilage regeneration. The bioactive components can improve content of hyaluronic acid in the body, reduce cartilage loss and maintain morphology of cartilage and synovial fluid. The active ingredients of Chinese herbs comprise fructus liquidambaris extract, herba lycopodii extract, fructus morinda citrifolia and ginger root extract, and have the effects of relaxing tendons and activating collaterals, promoting blood circulation to remove blood stasis, improving local microcirculation and relieving pain. According to the biological agent, Chinese medicines and western medicines are combined to fundamentally prevent and relieve joint inflammation.

The invention discloses an autologous joint fluid source mesenchymal stem cell repair cartilage injury image segmentation method based on multi-modal magnetic resonance. The method comprises the following steps of S1, collecting a cartilage injury image, S2, carrying out image visualization processing, S3, carrying out image edge detection, S4, extracting characteristic parameters, S5, extractingseed points, S6, selecting non-seed points, S7, updating the regional gray average value and the pixel standard deviation K of all the seed points in a growth region, and S8, finishing image acquisition. According to the method, 15-20 characteristic parameters are extracted from each edge; wherein the information features comprise edge local information features, edge geometric information features and information features between edge adjacent voxels, the features of different edge lines can be fully embodied, the classification screening precision is improved, and the method realizes intelligent selected image segmentation through self-adaptive seed point extraction and algorithm screening, and improves the image processing speed.

A chamber for testing the reactivity of patient fluids to a metallic implant alloy, such as CoCrMo, and a method of determining the reactivity of the patent to the alloy. A sealed mini-electrochemical cell incorporates the alloy surface as well as reference and counter electrodes coupled to a potentiostat for performing electrochemical measurements of the alloy surface while it is in direct contact with freshly harvested human fluids. Freshly obtained body fluids are thus assessed in terms of their bioelectrochemical reactivity with the alloy surface as a measure of the likely reactivity of the patient to the alloy if it were to be implanted into the patient.

The invention relates to a composition for preventing and treating joint soft tissue injury and complications thereof. A complex formulation, which comprises bone collagen, sodium hyaluronate, mangosteen extract, pomegranate extract and vitamin C in specific proportions, is prepared. The composition has an anti-inflammatory effect, since the generation of PGE2 is reduced by lowering the activity of COX2. Meanwhile, the composition accelerates the restoration and generation of cartilage tissue and joint fluid and lowers the degree of joint inflammation.

Tissue implants prepared for the repair of tissues, especially avascular tissues such as cartilage. One embodiment presents an electric potential capable of receiving and accumulating desirable factors or molecules from surrounding fluid when exposed to dynamic loading. In another embodiment the implant promotes tissue conduction by retarding, restricting and controlling cellular invasion through use of gradients until competent tissue forms. Further embodiments of the tissue implants may be formed into a multi-phasic device that provides deep tissue mechanical stimulus by conduction of mechanical and fluid forces experienced at the surface of the implant.